The Business Brew8 Apr 2021

Kyle Cerminara - All In

Please see https://www.fgfinancial.com/corporate-overview/officers-directors/default.aspx for Kyle's official bio. Kyle "stopped by" The Business Brew to discuss his role as CEO of Fundamental Global. In that capacity, he is focused on four portfolio companies: Ballantyne Strong Inc, BK Technologies Corp, GreenFirst Forest Products Inc, and SPAC that reached a definitive agreement to purchase Opportunity Financial. Kyle has a very interesting background. He is mentioned in David Einhorn's book, Fooling Some of the People All of the Time, because he crossed paths with David on the Allied Capital trade. At that time, Kyle was a Financial Services analyst at T. Rowe Price. Following his stint at T. Rowe Price, Kyle worked at SAC. Following his time at T Rowe Price, Kyle founded Fundamental Global with his partner Joe Moglia. Together, they take control of companies and look to create long term shareholder value. In this episode, Kyle discusses why he does what he does, how he thinks about value creation, and what he is trying to accomplish. Bill and Kyle met when Mike Mitchell was The Business Brew's first guest. Since that time, Bill has watched Kyle work tirelessly to execute his plans. Consequently, Bill has grown to respect Kyle very much and wanted to feature Kyle as a guest. This episode may give a glimpse into a fantasy many investors seem to have: buying controlling interests in companies. Bill's conclusion is he would rather partner with Kyle and let Kyle do the heavy lifting of execution. Disclosure: Bill owns shares in 3 of Kyle's companies. He won't name which ones because he doesn't want people to read anything into his decisions. However, he will commit to hold every share for at least a year following this podcast episode.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(202)

Steve Hou - Data Over Narrative

Steve Hou, Head of Research at Silicon Data, stops by to discuss solving problems associated with AI capex financing. Silicon Data provides users with a number of indices and data sets tracking everyt...

23 Sep 1h 16min

Another Cyclical Masterclass with Robotti & Company

Bob Robotti stops by for a follow up episode. David Kessler, Portfolio Manager and Securities Analyst at Robotti & Company, is in the room with Bob to provide some additional analytical firepower. Thi...

27 Aug 1h 38min

Another FDA vs uniQure Episode

Peter Mantas returns to the show. This is a follow up episode to the episode discussing uniQure. It's timely given the amount of media attention Marty Makary is getting; in part because of uniQure. De...

7 Maj 1h 20min

Revisiting Fairfax Financial

Charles Frischer and Asheef Lalani stop by The Business Brew to update the listeners on Fairfax Financial. They originally came on the program on 7/20/2023 when the stock was quite unloved. Bill asked...

30 Apr 1h 31min

Evan Tindell

Evan Tindell, CIO at Bireme Capital, returns to The Brew for a laid back conversation. The impetus for the conversation is Evan's Q4 letter. A year ago Evan came on the show to educate people about ...

24 Apr 1h 37min

Sonu Chawla - Managing Mid Cap Exposure - $TSCM

Sonu Chawla of Times Square Capital Management shares her investment philosophy, focusing on growth with a conscience, valuation discipline, and management assessment. Stocks discussed include Argenx,...

26 Mars 1h 12min

Notes From The Beauty Contest

@crashkolnikov on X, and author of Notes From The Beauty Contest Substack, joins the show. Notes From The Beauty Contest is a long form Substack that focuses on stocks that are somewhat under covered ...

21 Mars 1h 51min

Current Events - uniQure and the FDA

uniQure is a business that develops gene therapies. uniQure's AMT-130 is currently in the headlines. This podcast episode attempts to present the Huntington's Disease community's arguments for why the...

6 Mars 1h 35min